SCHEMBL19912484

SCHEMBL19912484

Cc1cccc(-c2ccc3c4ccc(-c5cccc(C)c5)cc4n(-c4cc(C#N)cc(-n5c6cc(-c7cccc(C)c7)ccc6c6ccc(-c7cccc(C)c7)cc65)c4-c4cc(C)cc(C)c4)c3c2)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AR P10275 1/20 0.39
GRIA2 P42262 1/20 0.37
GRIA4 P48058 1/20 0.37
KDM4A O75164 1/20 0.37
KDM5B Q9UGL1 1/20 0.37
CYP11B1 P15538 1/20 0.36
CYP11B2 P19099 1/20 0.36
MAPK14 Q16539 1/20 0.34
SIRT2 Q8IXJ6 2/20 0.34
ALDH1A1 P00352 2/20 0.33
TP53 P04637 2/20 0.33
HPGD P15428 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
HSD17B10 Q99714 2/20 0.33
MAPK1 P28482 2/20 0.33
KDM4E B2RXH2 1/20 0.33
LMNA P02545 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP2C9 P11712 1/20 0.33
TSHR P16473 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19913281 0.91 KDM4A (0.37) ARGRIA2GRIA4KDM4AKDM5B
SCHEMBL21546984 0.90 GRM5 (0.37) ARGRIA2GRIA4ALDH1A1TP53
SCHEMBL21414253 0.90 GRM5 (0.37) KDM5BALDH1A1GRM5CHEK1
SCHEMBL19912352 0.88 ALDH1A1 (0.38) ALDH1A1GRM5
SCHEMBL19913158 0.88 MAPK14 (0.45) ARGRIA2GRIA4KDM4AKDM5B
SCHEMBL25658965 0.88 CYP11B1 (0.38) ARGRIA2GRIA4KDM4AKDM5B
SCHEMBL19917967 0.88 AR (0.44) ARGRIA2GRIA4CYP11B1CYP11B2
SCHEMBL22822601 0.88 AR (0.44) ARGRIA2GRIA4ALDH1A1TP53
SCHEMBL19913277 0.87 KDM4A (0.35) ARGRIA2GRIA4KDM4AKDM5B
SCHEMBL21546479 0.86 GRIA2 (0.39) ARGRIA2GRIA4ALDH1A1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180062086-A1 ORGANIC MOLECULES, ESPECIALLY FOR USE IN ORGANIC OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2018-03-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180062086-A1 ORGANIC MOLECULES, ESPECIALLY FOR USE IN ORGANIC OPTOELECTRONIC DEVICES OR10J3, ORC3, AOC3 AR 4212/4885GRIA2 3141/4885GRIA4 3596/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.